Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat ...
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...
GlobalData on MSN9h
Precision reports initial outcomes from Hepatitis B trial of PBGENE-HBVThe trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.
Precision BioSciences reports early PBGENE-HBV trial data showing safety and antiviral activity in chronic Hepatitis B patients, with more results expected in 2025.
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback